Icelandic medicines agency

On Tuesday, the European Union’s drug regulator expanded its investigation into the risk of suicidal thoughts and self-injury among patients taking weight loss and diabetes medications, including those produced by Novo Nordisk (NASDAQ:NVO). The probe now encompasses about 150 reported cases...